CardioFocus Inc.
CardioFocus Inc. of Marlborough, Mass., developer of the HeartLight endoscopic ablation system for treatment of atrial defibrillation, has announced that a patient was treated with the visually guided device in a US clinical trial. The system incorporates an endoscope for direct visualization of a beating heart, in real time and without radiation. It uses laser energy for efficient and precise ablation. The trial will randomize HeartLight against the NaviStar Thermocool catheter. Only a single ablation procedure with HeartLight will be permitted, while repeat ablation may be performed with Thermocool. The trial will randomize about 350 patients at up to 25 US centers.
LATEST NEWS